Healthcare Giant CSL Slumps on ASX

Healthcare giant CSL slumps on ASX

CSL’s shares have crashed a staggering $21bn in the biggest plunge in the pharmaceutical giant’s history, dragging the ASX down along with it.

Healthcare giant’s $21bn loss sinks ASX200

CSL’s shares have crashed a staggering $21bn in the biggest plunge in the pharmaceutical giant’s history, dragging the ASX down along with it.

CSL share plunge delivers killer blow to active fund managers

The nation’s top stock-pickers sought refuge from excessively valued banks by piling into the healthcare giant. It worked, until it didn’t.

CSL Plunge Rocks Fund Managers

Australian fund managers are reeling after a significant drop in CSL’s share price. The near 17 per cent plunge on Tuesday, the stock’s biggest single-day fall, dragged down the broader sharemarket, particularly impacting those funds that had built overweight positions in the healthcare giant. CSL comprises just under 5 per cent of the S&P/ASX 200 Index. CSL is a global biotechnology company that researches, develops, manufactures, and markets a…

Closing Bell: ASX mugged by healthcare losses, down 0.7pc as sector freefalls

ASX bulls take a breath as market falls 0.7pc Healthcare leads losses, down 8.7pc Biotech heavyweight CSL suffers worst single day losses in decades   Healthcare sector in need of resuscitation The ASX has given up its bull rush for the moment, retreating 0.7% or 63 points from all-time highs. All fingers are pointing to healthcare as the culprit, down a shocking 8.73% in a single day. Energy wasn’t helping matters either, shedding 2.2%. There w…

Market Close: CSL Tuesday's villain as the healthcare mammoth helps sink XJO

Good Afternoon and welcome to HotCopper’s Market Close for Tuesday 19th of August, I’m Jon Davidson. All good things come to an end, and that’s been true on Tuesday for the bull run we’ve been enjoying lately – though, healthcare giant CSL’s less than fantastic results helped mint a red Tuesday.  Looking at sectors, IT scraped through as the top gainer up three quarters of a percent for most of intraday trades, as mentioned, healthcare led the l…